Phentermine

Class Anorectic
Chemistry

Phenylethylamine

Routes of administration

oral

Absorption

Almost 100% bioavailability

Solubility

pKa = 10.11, good water solubility; enough lipid solubility to cross the blood-brain barrier

Distribution

VOD= 5L/kg, 17.50% protein-bound

Metabolism

The majority of a dose (70-80%, some sources estimate higher) is excreted unchanged in urine; the portion which is metabolised is metabolised primarily by CYP3A4.

Elimination

Minimal free drug is eliminated in the urine

Time course of action

Half-life ~20 hours

Target receptor

The intracellular receptor TAAR1, which is activated and causes the internalisation or transporter reversal of DAT, NET and SERT (as well as vesicular monoamine transporter VMAT2 and MAO which are inhibited)

Mechanism of action

By increasing the synaptic concentration of noradrenaline and dopamine, amphetamine-like drugs acts as indirect sympathomimetics. Because they act centrally, this effect translates into increased alertness and arousal, as well as broadly adrenaline-like peripheral effects. Phentermine is a modified cogener of amphetamine and has less effects on dopamine activity, which is thought to reduce its abuse potential.

Clinical effects

Increased alertness as well as nausea, vomiting, abdominal cramps, hypertension, tachycardia, exacerbation of motor tics, lower seizure threshold. Anorexia is an expected and desired effect.

Literature reference

Lewis et al, 2024

CICM details of understanding Not specifically listed in the CICM syllabus
Mentioned around Deranged Physiology
Related SAQs